Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. Euglena Co., Ltd.
  6. Summary
    2931   JP3944370000

EUGLENA CO., LTD.

(2931)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Japan Exchange
06/14/2021 06/15/2021 06/16/2021 06/17/2021 06/18/2021 Date
886 902 905 886 889 Last
1107200 1018500 1078900 1173600 1585300 Volume
+0.11% +1.81% +0.33% -2.10% +0.34% Change
Financials
Sales 2021 15 500 M 141 M 141 M
Net income 2021 -1 090 M -9,89 M -9,89 M
Net Debt 2021 2 400 M 21,8 M 21,8 M
P/E ratio 2021 -76,0x
Yield 2021 -
Sales 2022 41 700 M 378 M 378 M
Net income 2022 700 M 6,35 M 6,35 M
Net Debt 2022 10 500 M 95,3 M 95,3 M
P/E ratio 2022 119x
Yield 2022 -
Capitalization 97 559 M 885 M 885 M
EV / Sales 2021 6,45x
EV / Sales 2022 2,59x
Nbr of Employees 357
Free-Float 85,8%
More Financials
Company
euglena Co., Ltd. is a Japan-based company mainly engaged in the healthcare, energy and environmental business utilizing the research and development results on euglena. The Company masters the core technology of euglena, which provides the edibility of microalga euglena (Japanese name: Midorimushi) and the technology of outdoor large-scale cultivation. The Company operates in two business segments. The Healthcare... 
Sector
Food Processing
Calendar
08/11Earnings Release
More about the company
Ratings of Euglena Co., Ltd.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about EUGLENA CO., LTD.
05/24Euglena Widens Loss in Fiscal Half Year; Shares Fall 3%
MT
05/24EUGLENAá : Summary of Consolidated Financial Results for the Six Months Ended Ma..
PU
03/16Euglena Produces Renewable Jet Fuel from Blend of Microalgae-Derived Lipids, ..
MT
03/15EUGLENAá : CLG and ARA Announce Successful Production of Renewable Jet Fuel
PU
2020Nikkei ends lower as rising COVID-19 infections sap risk appetite
RE
2020Nikkei slips as rising COVID-19 infections sap risk appetite
RE
2019ITOCHUá : Japanese firms start growing euglena abroad for biofuel
AQ
2016Japan central bank turns activist investor to revive economy
RE
More news
News in other languages on EUGLENA CO., LTD.
03/16MÄRKTE ASIEN/Rundum Gewinne - US-Vorgaben stützen Technologiewerte
More news
Chart EUGLENA CO., LTD.
Duration : Period :
Euglena Co., Ltd. Technical Analysis Chart | 2931 | JP3944370000 | MarketScreener
Technical analysis trends EUGLENA CO., LTD.
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 1
Average target price 900,00 JPY
Last Close Price 889,00 JPY
Spread / Highest target 1,24%
Spread / Average Target 1,24%
Spread / Lowest Target 1,24%
EPS Revisions
Managers and Directors
NameTitle
Mitsuru Izumo President & Representative Director
Kengo Suzuki Executive Officer, Head-Research & Development
Shuji Endo Manager-Information System
Daisuke Susa Executive Officer & Manager-Administration
Makoto Shimizu Independent Outside Director
Sector and Competitors
1st jan.Capitalization (M$)
EUGLENA CO., LTD.14.86%881
BY-HEALTH CO., LTD.42.82%8 684
HERBALIFE NUTRITION LTD.6.91%5 550
BALCHEM CORPORATION14.29%4 271
THE SIMPLY GOOD FOODS COMPANY14.29%3 432
MEDIFAST, INC.38.88%3 148